CRKN · As filed with the SEC
Crown Electrokinetics income statement, by quarter
The statement as Crown Electrokinetics presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Operations and Comprehensive Loss · USD thousands, except per-share amounts
| USD thousands, except per-share amounts | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 | Q3 2024 3 months ended Sep 30, 2024 | Q2 2024 3 months ended Jun 30, 2024 | Q1 2024 3 months ended Mar 31, 2024 | Q4 2023† 3 months ended Dec 31, 2023 | Q3 2023† 3 months ended Sep 30, 2023 | Q2 2023† 3 months ended Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2,772 | 6,334† | 8,037 | 4,648 | 682 | 94† | 0† | 37 |
| Cost of revenue | — | — | 6,623 | (4,039) | (1,636) | (940)† | 108† | 23 |
| Depreciation and amortization | — | — | — | (219) | (212) | — | — | (81)† |
| Nonrelated Party | 2,792 | — | — | — | — | — | — | — |
| Related Party | 997 | — | — | — | — | — | — | — |
| Gross margin | (1,017) | (1,639)† | 1,414 | — | — | (786)† | 0† | 14 |
| Operating expenses: | ||||||||
| Research and development | 1,219 | 1,422† | 720 | (1,111) | (756) | (3,754)† | 492 | 490 |
| General and administrative | — | — | 6,507 | (4,187) | (1,783) | — | 18,648† | (4,328)† |
| Selling, general and administrative | 7,664 | — | — | — | — | (25,888)† | 2,941 | 4,409 |
| Total operating expenses | 8,883 | 8,062† | 7,227 | — | — | 6,078† | 3,433 | 4,899 |
| Loss from operations | (9,900) | (9,701)† | (5,813) | (4,908) | (3,705) | (6,864)† | (3,433) | (4,885) |
| Interest expense | — | — | — | — | (860) | (2,447)† | (2,445) | (2,508) |
| Non-operating income (expense), net: | ||||||||
| Interest expense | — | 7† | 0 | (145) | — | (2,447)† | (2,445)† | — |
| Loss on extinguishment of warrant liability | — | 0† | 0 | 0 | 0 | 0† | 0† | (2,345) |
| Loss on extinguishment of debt | — | 0† | 0 | 0 | — | 0† | 0† | 0† |
| Gain on issuance of convertible notes | — | 0† | 0 | 0 | 0 | 0† | 0† | 0† |
| Change in fair value of warrants | — | — | — | — | — | — | — | 2,130 |
| Interest income (expense), net | 198 | — | — | — | — | — | — | — |
| Change in fair value of warrants | 0 | 0† | 0 | 23 | (23) | 34† | 2,688 | 2,130† |
| Change in fair value of notes | — | 0† | 0 | 0 | 0 | 0† | (40) | (6,883) |
| Other expense | — | — | — | — | (24) | (29)† | (30) | (28) |
| Change in fair value of derivative liability | — | 0† | 0 | — | — | 0† | — | — |
| Realized loss from ELOC derivative | — | — | — | — | — | (401)† | 401 | — |
| Other income (expense), net | 18 | 53† | (51) | 1 | — | (29)† | (30)† | — |
| Total non-operating income (expense), net | 216 | (740)† | (51) | (121) | (907) | (2,442)† | 574 | (9,634) |
| Loss before income taxes | — | — | — | (5,029) | (4,612) | (9,306)† | (2,859) | (14,519) |
| Income tax expense | — | — | — | 0 | 0 | — | — | 0† |
| Net loss and comprehensive loss | (9,684) | (10,441)† | (5,864) | (5,029) | (4,612) | (9,306)† | (2,859) | (14,519) |
| Deemed dividend | — | — | — | — | 0 | 0† | 0† | 0† |
| Cumulative dividends on Series D preferred stock | — | 0† | 0 | 0 | — | 0† | 0† | — |
| Preferred Stock Series A, B and C | — | (797)† | 0 | (1,350) | — | 0† | 0† | — |
| Preferred Stock Series F, F-1, and F-2 | — | 0† | 0 | (3,874) | — | 0† | 0† | — |
| Cumulative dividends on Series A preferred stock | 0 | 0† | 0 | 0 | (5) | (5)† | (5) | (5) |
| Cumulative dividends on Series B preferred stock | 0 | 0† | 0 | 0 | (29) | (29)† | (29) | (29) |
| Cumulative dividends on Series C preferred stock | 0 | 0† | 0 | 0 | (10) | (10)† | (10) | (10) |
| Cumulative dividends on Series D preferred stock | — | 0† | 0 | 0 | 0 | 0† | 31† | (53) |
| Cumulative dividends on Series F preferred stock | 0 | 0† | 0 | — | (178) | 80† | (144) | — |
| Cumulative dividends on Series F-1 preferred stock | 0 | 0† | 0 | — | (26) | (39)† | (51) | — |
| Cumulative dividends on Series F-2 preferred stock | 0 | 0† | 0 | — | (35) | (35)† | (44) | — |
| Cumulative dividends on Series A preferred stock | 0 | — | — | — | — | — | — | — |
| Cumulative dividends on Series B preferred stock | 0 | — | — | — | — | — | — | — |
| Cumulative dividends on Series C preferred stock | 0 | — | — | — | — | — | — | — |
| Cumulative dividends on Series F preferred stock | 0 | — | — | — | — | — | — | — |
| Cumulative dividends on Series F-1 preferred stock | 0 | — | — | — | — | — | — | — |
| Cumulative dividends on Series F-2 preferred stock | 0 | — | — | — | — | — | — | — |
| Net loss attributable to common stockholders | (9,684) | (11,238)† | (5,864) | (10,253) | (4,895) | (9,506)† | (3,142) | (14,616) |
| Net loss per share attributable to common stockholders (in Dollars per share) | — | — | — | — | — | — | — | (18.02) |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | (5.79) | — | (1.26) | (5.89) | (0.13) | — | (0.94) | — |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | (5.79) | — | — | — | — | — | — | — |
| Weighted Average Number of Shares Outstanding, Basic and Diluted | ||||||||
| Weighted average shares outstanding, basic (in shares) | 1,672,581 | — | 4,662,086 | 1,739,995 | 36,675,540 | — | 3,349,195 | 810,983 |
| Weighted average shares outstanding, diluted (in shares) | 1,672,581 | — | 4,662,086 | 1,739,995 | 36,675,540 | — | — | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.